Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
8,733,333
-
Share change
-
-1,566,637
-
Total reported value
-
$18,344,069
-
Put/Call ratio
-
214%
-
Price per share
-
$2.10
-
Number of holders
-
37
-
Value change
-
-$3,514,674
-
Number of buys
-
17
-
Number of sells
-
23
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q4 2022
As of 31 Dec 2022,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,733,333 shares.
The largest 10 holders included
Long Focus Capital Management, LLC, CREDIT SUISSE AG/, PRINCIPAL FINANCIAL GROUP INC, MILLENNIUM MANAGEMENT LLC, BAILLIE GIFFORD & CO, Capital International Investors, Capital World Investors, D. E. Shaw & Co., Inc., MACQUARIE GROUP LTD, and JANE STREET GROUP, LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.